Leveraging Natural History of Disease Studies for Integrated Evidence Generation Plans and Regulatory Success

Natural history of disease studies are intended to track the course of a disease by identifying demographic, genetic, environmental, and other variables (e.g., treatments, concomitant medications) that correlate with the disease’s development and outcomes. Natural history of disease studies play a crucial role in integrated evidence generation plans, especially for rare diseases and conditions where… Continue reading Leveraging Natural History of Disease Studies for Integrated Evidence Generation Plans and Regulatory Success

Process for Health Technology Assessments (HTAs) in France

Health Technology Assessments (HTAs) in France are a key component of the healthcare system, used to evaluate the clinical efficacy, safety, and cost-effectiveness of new medical technologies, including drugs, devices, and procedures. The HTA process in France is highly structured and involves several key organizations, each with distinct roles and responsibilities.     1. High… Continue reading Process for Health Technology Assessments (HTAs) in France

Joint Clinical Assessments: Harmonizing Medicine Evaluations Across Europe Under EMA Regulations

A Joint Clinical Assessment (JCA) refers to a coordinated evaluation of the clinical evidence of a medicine’s efficacy, safety, and therapeutic value, conducted by multiple health technology assessment (HTA) bodies across Europe. This process aims to streamline and harmonize the assessment procedures, ensuring that all participating countries have access to consistent and high-quality clinical evaluations.… Continue reading Joint Clinical Assessments: Harmonizing Medicine Evaluations Across Europe Under EMA Regulations

Process for Health Technology Assessments (HTAs) in Germany

Health Technology Assessments (HTAs) in Germany are essential to evaluating the benefits, risks, and economic implications of medical technologies and interventions. The process involves several key institutions. These bodies have distinct roles in evaluating and deciding on the inclusion and reimbursement of health technologies within the healthcare system. Before looking at the process, let’s explore… Continue reading Process for Health Technology Assessments (HTAs) in Germany